Ligand Pharma Pounded
Ligand Pharmaceuticals (LGND Quote) shares dropped almost 17% after the company announced a first-quarter loss that was better than a year ago, but missed Wall Street expectations by a wide margin.
Ligand announced a first-quarter net loss of $10.3 million, or 18 cents a share, an improvement from the loss of $12.6 million, or 29 cents a share. While Ligand continues to staunch its losses, the company missed the Wall Street estimate of a 6-cent loss by a wide margin.
The results disappointed investors, who moved to sell shares early Wednesday morning, dropping Ligand shares $3.66, or 16.9%, to $18 million on 2.9 million shares traded, well above its average daily trading volume of 1.8 million shares. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,471.50 | 1,106.41 | 2,190.31 | 35.40 |
Oil *
71.66
|
|
UP
65.67
|
UP
4.06
|
DOWN
0.55
|
UP
0.58
|
10 Yr
3.54%
SPDR Gold
109.32
|
|
+0.63%
|
+0.37%
|
-0.03%
|
+1.67%
|
Data delayed 20 minutes |


Connect with TheStreet